Patent · US Active

Amorphous form of rifaximin and processes for its preparation

US7709634B2 · kind B2 · utility

32Cited by
6References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2007
Grant dateMay 4, 2010
Priority date
Expiry dateSep 20, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/22
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A stable amorphous form of rifaximin is disclosed. This form is chemically and polymorphically stable on storage and can be prepared by dissolving rifaximin in a solvent to form a solution, which is precipitated by adding an anti-solvent and isolating of the precipitated amorphous rifaximin as an end product.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.